Page last updated: 2024-10-21

acebutolol and Cerebral Infarction

acebutolol has been researched along with Cerebral Infarction in 1 studies

Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.

Cerebral Infarction: The formation of an area of NECROSIS in the CEREBRUM caused by an insufficiency of arterial or venous blood flow. Infarcts of the cerebrum are generally classified by hemisphere (i.e., left vs. right), lobe (e.g., frontal lobe infarction), arterial distribution (e.g., INFARCTION, ANTERIOR CEREBRAL ARTERY), and etiology (e.g., embolic infarction).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azuma, T1
Matsubara, T1
Nagai, Y1
Funauchi, M1
Fujimoto, T1
Saito, T1
Tone, K1
Sakoda, S1

Trials

1 trial available for acebutolol and Cerebral Infarction

ArticleYear
Effects of antihypertensive agents on circadian blood pressure in hypertensive patients with previous brain infarction.
    Journal of human hypertension, 1997, Volume: 11, Issue:10

    Topics: Acebutolol; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Ca

1997